<DOC>
	<DOCNO>NCT00773812</DOCNO>
	<brief_summary>The purpose study examine safety efficacy mecamylamine core symptom autism .</brief_summary>
	<brief_title>Placebo-Controlled Pilot Trial Mecamylamine Treatment Autism Spectrum Disorders</brief_title>
	<detailed_description>This placebo-controlled pilot clinical trial nicotinic agent base evidence disturbance occur nicotinic cholinergic transmission brain autistic child . This pharmacotherapeutic trial conduct direct result finding nicotinic receptor abnormality autopsied brain tissue individual suffer autism . A pharmacological agent , mecamylamine , specificity nicotinic receptor implicate autism , test child autism spectrum disorder . Twenty child meet inclusion/exclusion criterion randomize 2:3 ratio 14 week either match placebo ( n=8 ) mecamylamine ( n=12 ) . Children randomize placebo respond give opportunity enroll ten week open label extension . The trial complete publish J. Child &amp; Adolescent Psychopharmacology .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Developmental Disabilities</mesh_term>
	<mesh_term>Mecamylamine</mesh_term>
	<criteria>Autistic Disorder Pervasive Developmental DisorderNot Otherwise Specified Age 412 General good health IQ &gt; =36 mental age &gt; =18 month Parent/caregiver willingness accompany child clinic monitor side effect Unstable Seizure Disorder Psychoactive medication process adjustment Antipsychotic medication previous 3 month baseline Systemic corticoid ( inhaler allow ) Planned begin major behavioral intervention 3 month study 2 month prior study .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Autistic Disorder</keyword>
	<keyword>Autism</keyword>
	<keyword>Mecamylamine</keyword>
	<keyword>Pervasive Developmental Disorder-Not Otherwise Specified</keyword>
</DOC>